Literature DB >> 23103704

Mass spectrometry-based quantification.

Leroi V DeSouza1, K W Michael Siu.   

Abstract

OBJECTIVE: This review describes the most common methods currently used for mass spectrometry-based quantification in proteomic applications. DESIGN AND METHODS: Quantification can be performed using either labeled or unlabeled approaches. Labeled approaches rely on mass-tagging of peptide reference standards either by direct synthesis or through chemical or metabolic means. Following labeling, samples are pooled and analyzed as one, thereby circumventing any potential error that could result from run-to-run variability. Unlabeled approaches rely on run-to-run comparisons between test and reference samples and assume a highly reproducible separation and similar sample compositions.
RESULTS: A number of commercial labeling reagents are now available and each of these are described along with their strengths and limitations.
CONCLUSIONS: The choice of method will ultimately depend, not just on financial considerations, but also on the context of the experiment.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 23103704     DOI: 10.1016/j.clinbiochem.2012.10.025

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

Review 1.  Environmental proteomic studies: closer step to understand bacterial biofilms.

Authors:  Anupama Rani; Subramanian Babu
Journal:  World J Microbiol Biotechnol       Date:  2018-07-18       Impact factor: 3.312

Review 2.  Making proteomics data accessible and reusable: current state of proteomics databases and repositories.

Authors:  Yasset Perez-Riverol; Emanuele Alpi; Rui Wang; Henning Hermjakob; Juan Antonio Vizcaíno
Journal:  Proteomics       Date:  2015-03       Impact factor: 3.984

3.  iTRAQ as a method for optimization: enhancing peptide recovery after gel fractionation.

Authors:  Pieter Glibert; Katleen Van Steendam; Maarten Dhaenens; Dieter Deforce
Journal:  Proteomics       Date:  2014-02-18       Impact factor: 3.984

4.  Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.

Authors:  Maria Frantzi; Akshay Bhat; Agnieszka Latosinska
Journal:  Clin Transl Med       Date:  2014-03-29

Review 5.  Proteomic Workflows for Biomarker Identification Using Mass Spectrometry - Technical and Statistical Considerations during Initial Discovery.

Authors:  Dennis J Orton; Alan A Doucette
Journal:  Proteomes       Date:  2013-08-27

Review 6.  Bioinformatics Resources for Plant Abiotic Stress Responses: State of the Art and Opportunities in the Fast Evolving -Omics Era.

Authors:  Luca Ambrosino; Chiara Colantuono; Gianfranco Diretto; Alessia Fiore; Maria Luisa Chiusano
Journal:  Plants (Basel)       Date:  2020-05-06

7.  3D Visualization of the Dynamic Bidirectional Talk Between ER/PR and Her2 Pathways.

Authors:  Jiahong Lyv; Guohua Yu; Yunyun Zhang; Yan Lyv; Wenfeng Zhang; Jiandi Zhang; Fangrong Tang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc.

Authors:  William Mark Erwin; Leroi DeSouza; Martha Funabashi; Greg Kawchuk; Muhammad Zia Karim; Sarah Kim; Stefanie Mӓdler; Ajay Matta; Xiaomei Wang; K Arne Mehrkens
Journal:  Arthritis Res Ther       Date:  2015-09-05       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.